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Laboratory tests are extremely important in patient’s monitoring and/or diagnosing. We 
described those that are particularly significant for elderly patients, namely: peripheral blood  
morphology, arterial blood gasometry, cancer markers. The aim of this article is to 
summarize current knowledge about laboratory tests important in geriatrics, as well as draw 
attention to the diverse use of laboratory tests in clinical practise. 
 




Laboratory tests are used to find patients with diseases or people with some risk factors. 
Moreover they are used to make decisions about treatment and to estimate remission of 
disease [1]. What is important laboratory tests can be used to estimate  advance routine frailty 
assessment, especially in combination with other appropriate parameters from medical 
records [2]. 
 For example, one of the most used laboratory tests to health evaluation is Complete Blood 
Count (CBC) [3]. Many laboratory indicators including apoA1, apoB, homocystein, hsCRP 
or albumin in urine play a role in risk assesment of cardiovascular diseases or diabetes 
mellitus. There is some clinical tests that ApoA1 concentration increase with age. Moreover, 
homocysteine concentration is observed to be lower in adult women than adult men, which 
have a cardioprotective effect in this group. What is more there are some recent guidelines 
from the Canadian and American Diabetes Associations that  concentration of HbA1c should 
be used for diagnosing type 2 diabetes and assesing the increased risk and pre-diabetic 
conditions. There some clinical reports that there are two partitions for HbA1c , one 
containing patients at age 6-39 years old and 40-79 years old. In the second age group 
observed slightly higher values of HbA1c concentration which are higher than the reference 
interval [4]. 
  Reference values are necessary to interpret results of laboratory tests and to 
management of patients in clinical conditions and research. Laboratory ranges are determined 
based on many factors : age, gender, dietary habits, ethnicity, and the environment. They 
must be appropriate for the proper population to correct interpretation [5]. 
There are some doubts whether haemoglobin and other haematology results, which are used 
for young adults, are legitimate for geriatric patients. Haemoglobin decrease with age 
especially comparing men to women. It is probably caused by some age- related conditions 
which can lead to reduce of haemoglobin, such as: decrease in the number of haematopoietic 
progenitors, smaller sensivity of these progenitors to growth factors and decrease in intensity 
of secretion of erythropoietin, which may cause to lower reference values for haemoglobin in 
laboratory results of older people compared to results of younger people [6]. 
  
Results 
1.  Blood morphology – the importance in clinical practice 
Blood morphology tests are basic ones of laboratory tests. The following is a description of 
the most important parameters: 
-WBC (white blood cells), among them NE (neutrophils), LY (lymphocytes), MO 
(monocytes) and MID (includes monocytes, eosinophils, basophils and abnormal cells, eg 
blastoma). If WBC are increased that means there is  leukocytosis, if they are  reduced that 
means there is  leukopenia. The increase of NE can suggest infection, the reduce might 
suggest lowering immunity for bacterial and fungal infections. LY increase may suggest 
chronic lymphatic leukemia. An anomaly LY decrease may suggest AIDS or granulomatous 
lymphoma. The increase of MID is the most dangerous all among leucoties, because they 
indicate serious types of leukemia. Furthermore  BASO (basophils) requires necessary 
hematological consultation; increase of EO (eosinophils) declaring that we are dealing with 
an allergy, a parasitic disease. 
-RBC (red blood cells), HGB (hemoglobin), HCT (hematocrite - the ratio of erythrocyte 
volume to whole blood volume). The disturbance of these parameters is closely related. The 
decrease may suggest anemia, while the increase of these parameters above the norm can 
suggest polycythemia. 
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-MCV (mean corpuscular volume) the increase of this parameter above the norm suggests 
about the increase of erythrocytes (macrocytes), while the decrease of this parameter below 
the standard tells us about the reduction of the size of erythrocytes (microcytes). 
-MCH (mean content of hemoglobin), MCHC (mean cell hemoglobin concentration) - if 
these parameters are below the norm it suggests that the erythrocytes are hipochromatic, 
while if they are above the norm it suggests hiperchromatic red blood cells. 
-Retics (immature forms of red blood cells) their number is an indicator of the production of 
red blood cells. 
-RDW (relative dimension width) is an index of anisocytosis that defines a variety of blood 
cell sizes. 
-PLT (platelets). 
The results of blood morphology are always given correct values and if any parameter 
deviates from the norm it is marked with the letters H (high) or L (low). The more the given 
parameter deviates from the norm, the more serious the illness affects, and small deviations 
from the norm may suggest the beginning of some diseases or may be completely accidental. 
Large deviations from the norm inform us about the disease but it does not have to affect 
blood diseases. Only further diagnostics will help  to make the right diagnosis. If we interpret 
the result of the blood morphology and there are deviations from the norm, the earlier results 
of the patient's examinations are very helpful. They show whether such abnormalities 
occurred before [1]. 
In acute leukemia, a neoplastic disease of the hematopoietic system characterized by clonal 
proliferation, abnormal maturation and release of white blood cells into the peripheral blood, 
all parameters except the MCV change [2]. WBC is significantly elevated. NE, LY, MO and 
MID are significantly increased depending on the type of leukemia, only one or several 
parameters may increase at the same time. RBC and PLT are usually lowered because they 
are replaced by white blood cell cells, which can lead to anemia and thrombocytopenia. 
Based on the blood morphology, we can not determine a specific type of leukemia, whether it 
is meyloid or lymphoblastic. Immunophenotyping and genetic testing should be used for 
further diagnosis. In Chronic Lymphocytic Leukemia, that is B-cell monoclonal 
lymphocytosis, which lasts at least 3 months, will increase, but not as much as in the case of 
acute leukemia WBC and LY while maintaining other parameters in the norm or deviating 
from the norm [3]. Genetic research will be needed here, because it may also be suggested by 
leukemic reaction. 
Significantly elevated RBC, while maintaining the norm of other parameters, may indicate a 
myeloproliferative syndrome, whose complication may be transformation to acute leukemia 
[4]. It may be secondary to eg lung disease. However, a significant reduction in RBC may 
indicate anemia. Depending on the parameters described above, MCV, MCH and MCHC 
may be microcytic or macrocytic, as well as hipochromatic, hiperchromatic or 
normochromatic. 
If PLT are significantly lowered, it may occur thrombocytopenia, which may lead to impaired 
wound healing and may even cause fatal haemorrhages, but if PLT are significantly elevated, 
it may cause excessive clotting, which may result in stroke or infarction or suggest a rare type 
of cancer blood called essential thrombocythemia [5]. 
 
2. Arterial blood gasometry (ABG) test - the importance in medical practise.  
 The evaluation of arterial blood gases was used, among others, in predicting further 
prognoses for patients with COPD. According to the collected data, blood gasometry, which 
is a simple procedure collected at the patient's bed, allows for quick analysis and change of 
treatment for patients. This is due to the main cause of COPD, which is smoking cigarettes. 
Hypercapnia and acidosis were shown for patients with severe COPD in gasometry. It turned 
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out that this is associated with a worse prognosis and a longer time of hospitalization of such 
patients. Regarding patients with a stable condition - such patients had normal blood gas 
values, which allowed for a shorter hospitalization and better prognosis [1]. 
Patients from the intensive care unit and hospitalized patients were tested for the parallel 
between venous and arterial blood gasometry. The aim was to find out whether venous blood 
is a good alternative to arterial blood in acid-base balance studies. Studies have shown that 
venous blood may allow us to initially assess the acid-base balance in critically ill patients. In 
addition, arterial blood gases can only be performed for confirmation. However, venous 
blood gasometry could be sufficient to check the patient's response to treatment [2]. 
Blood arterial gasometry was also studied in patients with severe head trauma. This factor 
was examined (along with others) to see how they relate to the prognosis of patients with 
traumatic brain injury. In this study, the obtained values were compared to the parameters of 
healthy people. Many laboratory parameters were tested, including PT, INR, Na. However, in 
the case of the ABG test, the pCO2 values, HCO3- and SO2 have changed significantly. As it 
turned out, it did not affect the prognostic value of patients with severe head trauma, as 
opposed to Cr, Na +, INR, PT, or GCS [3]. 
Other studies inform that diffrent marker can be also used in obese patients with acute 
dyspnea. Regarding to obese patients, arterial pH may selectively predicts critical care needs 
in ED. The authors of the study realised that pH <7,36 should be consider as a marker of 
severity when assessing acute dyspnea in obese ED patients. Arterial pH is independent 
predictor in obese patients, but it isn’t relevant in non-obese patients [4]. 
When taking arterial blood, it should be taken into account that arterial puncture is a painful 
procedure. For this reason, efforts are being made to introduce new blood collection 
techniques to clinical practice. Particular hopes are associated with collecting blood from 
capillaries, an example of which is the technique of puncturing capillaries from the earlobe, 
which has been promoted for decades as a substitute for puncturing arteries. In the following 
years, the issue of higher efficiency of blood collection from capillaries was raised in a study 
by Dar et al., in which participated 55 patients. Attention was drawn not only to the slight 
difference in the biochemical composition between blood taken from the artery and blood 
taken from the capillaries, but also to the benefits of much less pain when puncturing the 
earlobe [5]. This is particularly important in patients with low mental resistance to pain, so 
further efforts should be made to examine and promote capillary punctures for arterial blood 
testing. 
 
3. Geriatric cancer markers 
The most common types of male cancer are prostate, lungs & bronchus, colon&rectum and 
pancreas cancer. Female most frequently occurring cancer types are breast, lung&bronchus, 
colon&rectum and pancreas. There are some biochemical indicators of presence of a tumor 
named cancer markers that help to detect, differentiate and determine the risk of cancer. 
Although they are not perfect to detect tumor, they can be used to monitor treatment and to 
determine the prognosis. 
Carcinoembryonic antigen (CEA) is a high molecular weight glycoprotein belonging to the 
immunoglobulin superfamily of molecules [1]. CEA is being detected in serum and it is being 
used to detect colorectal carcinoma, pancreatic carcinoma, gastric and breast carcinoma. The 
tests are positive for colorectal cancer in 60-80%, less for pancreatic cancer- 50-80%, and for 
gastric and breast carcinoma at 25-50%. The level of CEA in serum also rise in many  benign 
disorders as alcoholic cirrhosis, hepatitis, ulcerative colitis [2]. It is not recommended to use 
CEA as a  screen for early stages of colorectal cancer, because of inadequate sensitivity in 
screening, but trends in CEA measurements apart form single test result are being used to 
monitor treatment of colorectal cancer and improve diagnostic accuracy for recurrence [1, 3]. 
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Estrogen receptor (ER) and progesteron receptor (PR) are very important indicators 
determining the validity of hormonotherapy for patients with breast cancer. ER and PR can 
be detected by enzyme‑linked immunosorbent assay (ELISA) or immunohistochemistry 
(IHC) from patient’s blood. 
Human epidermal growth factor-2 (HER2) – overexpression of this marker announces more 
aggressive disease with a poor prognosis. This marker should be quanified to select patients 
with breast cancer that may be treated with trastuzumab [4]. 
Prostate-specific antigen (PSA) is being produced either by healthy and malignant prostatic 
glands, that is why 67% of man with a high PSA do not have a cancer and 20% of man with 
cancer have PSA within the normal range. Furthermore this cancer marker’s level increases 
with age or in benign prostatic hyperplasia, urinary tract infection and digital rectal 
examination. Notwithstanding PSA is the basic marker used to detect early stage of yet 
curable prostate cancer, to monitor tumor recurrence or progression following definitive 
treatment [5]. There were some steps taken to improve specificity as measurements of free 
PSA, complexed PSA, PSA velocity, PSA density and age specific reference values [6]. 
CA-125 is the tumor marker for ovarian cancer and it is the most common marker used to 
detect this type od tumor because about 80% of patients with advanced ovarian cancer have 
increased level of CA-125. Unfortunately this marker is not perfect for the reason that only 
50-60% of patients with early-stage ovarian cancer have CA-125 above the normal level, and 
it also rise in such diseases like pancreatic cancer, breast cancer, bladder cancer, liver cancer, 
lung cancer, diverticulitis, cirrhotic, endometriosis, or in some physiological conditions like 
menstruation or pregnancy. That is why CA-125 should not be used for screening ovarian 
cancer [7]. 
  
4. The importance of laboratory tests in geriatric emergencies 
Laboratory diagnostics is a dynamically developing discipline of medicine. Research aimed 
at determining the biological and physicochemical parameters of blood essential for patients 
in emergency situations, eg in patients with stroke, are becoming more and more numerous in 
different parts of the world [1]. 
The most common laboratory tests performed in hospitals in both departments and 
emergency departments include peripheral blood counts, electrolytes, urea and creatinine, 
glucose and enzymes. It is also worth to assess the level of troponin I. In patients with stroke, 
such tests are primarily aimed at obtaining a general picture of the patient's condition. They 
also allow to determine the patient's condition, the degree of homeostasis of the organism and 
allow to explain the cause and pathogenesis of the disease. Other key parameters in the 
diagnosis of stroke include, but are not limited to, brain natriuretic peptide (BNP), von 
Willebrand factor (vWF), TNF-alpha, neurospecific enolase (NSE), leptin. An important and 
one of the most frequently studied biomarkers in the course of stroke is the brain natriuretic 
peptide (BNP). BNP is a peptide neurohormone produced by cardiac myocytes. The main 
task of BNP is to preserve homeostasis - namely the pressure and volume of circulating 
blood. Is secreted due to the increase in the extension of the heart muscle wall - as a 
consequence of volume or pressure overload. In the acute phase of the stroke, patients can be 
observed to increase the level of BNP in plasma and increase the concentration of its 
biologically inactive final fragments - NT-proBNP. The scientific study proves that the BNP 
concentration in plasma is elevated in people with cerebrovascular disease regardless of heart 
disease. Another parameter whose activity increases in the course of stroke is von Willebrand 
factor - vWF. It has been proven that there is a relationship between acute elevation of 
endothelial markers in the blood and platelet activation, and ischemic stroke. vWF is helpful 
in making decisions about the implementation of anticoagulant therapy, especially in patients 
who are in the group with moderate risk of stroke [2, 3, 4]. 
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Another sudden condition, a possible life-threatening condition is a pain in the chest area. In 
the diagnosis of myocardial infarction, it is preferable to test the concentration of high-
sensitivity cardiac troponins (hs-cTn) in the blood. This test is in line with the guidelines for 
the diagnosis of acute coronary syndromes. However, other tests, such as blood counts, 
coagulogram, lipidogram, determination of potassium, sodium and magnesium, creatinine, 
urea and glucose, must not be forgotten. All parameters studied have influence on making 
decisions regarding further treatment of the patient, they allow to assess the patient's current 
condition and homeostasis. Rapid diagnosis of patients with chest pain is important not only 
for proper behavior, but also for the hospital from the point of view of economics [1, 5, 6].  
 
5. The latest trends and directions of research 
Modern laboratory diagnostics can save lives. In many diseases, early diagnosis is crucial, 
which is why prevention and specialist examinations are so important.  From year to year 
they can  bring new diagnostic possibilities. 
Prostate cancer  is a very common disease among elderly men. PSA is a commonly used 
marker which can help in early detection of this cancer. Unfortunately, it appeared that  PSA 
participates in overdiagnosis of less agressive cancer [1]. Consequently, to reduce the 
overidentification of low risk cancers and improve the detection of those cancers which are 
clinically significant -  new blood-based biomarkers  have been taken into consideration. The 
4K panel have been developed and it is recommended to avoid prostate biopsy. 4K is a 
statistical model based on four kallikrein markers which combines total PSA, free-PSA, intact 
PSA, and Hk2  in blood. It accuracy in detecting the advanced prostate cancers is 
substantially high [2]. PHI, ExoDx, SelectMDx  are also recommended as biomarkers that 
can increase the diagnosis of clinically significant tumors and to select patients for biopsy. 
PCA3 and ConfirmMDx are for patients with suspicion of prostate cancer but with negative 
biopsy, to check if rebiopsy is needed. Oncotype DX and Decipher are prognostic and can be 
helpful in choosing whether the treatment should be radical or conservative. Decipher and 
Prolaris can be used in decision if adjuvant radiation therapy is needed [3]. 
When it comes to Alzheimer’s disease new studies have shown that cerebrospinal fluid 
biomarkers can  have a great diagnostic accuracy. The potential in using platelet tau protein  
in indication  of early stages of cognitive impairment is very promising [4]. Furthermore,  for 
early idiopatic Parkinson disease there is a potentially  useful and noninvasive biomarker 
such as salivary heme oxygenase‐1 which has been implicated in the pathogenesis of this 
disease [5]. 
Osteoporosis is a common disorder, especially affecting postmenopausal women. It is often 
diagnosed too late when the damage has already appeared. The fracture has a dangerous 
health outcomes so new biomarkers are needed to diagnose this disease in its early stages. 
There is a huge focus on miRNA and small noncoding RNA. They can be also used in 
stratification of risk and fractures [6]. 
It is important to look for new solutions all the time. Many diseases leave certain trails and 
scientists find it significant to research it and make it a new standard in diagnosis. 
  
Discussion  
The aim of our article is to draw attention to the diverse use of laboratory tests in clinical 
practice, as well as to show differences between their use in geriatric patients in relation to 
other patients. Laboratory diagnosis is helpful when determining the next stages of treatment, 
remission assessment and also when trying to select people with specific risk factors or 
diseases. An appropriate development of laboratory ranges takes into account gender, age, 
genetic and environmental determinants for a given population. This allows for a better 
interpretation of the research. 
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Indicators such as homocysteine, hsCRP or apoA1 are used to assess the risk in diabetes and 
cardiovascular diseases. It is worth noting that the reference ranges of parameters such as 
apoA1 or HbA1c may be higher in the elderly. However, for haemoglobin they may be lower 
than for the rest of the population. 
A change in the concentration of individual laboratory parameters may suggest specific 
disease entities, for example  MID increase may indicate serious types of leukemia, and a 
reduction in LY-AIDS anomalies or granulomatous lymphoma. A decrease in the PLT 
number leads to abnormal wound healing, and the increase to excessive clotting, which 
occurs in a rare condition that is essential thrombocythaemia. 
Arterial blood gas assessment can be used as a prognostic factor in COPD patients as well as 
in obese patients. In the first group, hypercapnia and acidosis increase the risk of prolonged 
hospitalization and unfavorable prognosis. However, in the case of obese patients with ED 
pH <7.36, it is an indicator of the severity of acute dyspnoea. 
Tumor markers are biochemical indicators used primarily to monitor treatment and determine 
prognosis. This function is performed by the estrogen and progesterone receptors in breast 
cancer or prostate specific antigen in prostate cancer. They are less frequently used in 
screening tests due to insufficient sensitivity. 
In emergency states such as a stroke, it is worth determininge the brain natriuretic peptide, 
von Willebrand factor or TNF-alpha. The level of BNP in plasma also increases in patients 
with cerebrovascular disease. Increasing troponin concentration with high sensitivity is the 
basis for diagnosing infarction. The above parameters should also be taken into account when 
assessing homeostasis and current patient status. 
Recent research indicates the possibility of using unknown markers, for example salivary 
heme oxygenase 1 in the course of idiopathic Parkinson's disease or miRNA in the 
stratification of risk and fractures in the case of osteoporosis. We want to encourage the 
medical community to seek new solutions for laboratory research, as well as to gain current 
knowledge about them, so that the patient's diagnosis becomes even faster and more accurate. 
 
Conclusions  
Blood laboratory tests are necessary in the care of a geriatric patient. The primary 
practitioner's task is to guide your patient in order to detect the most common diseases 
characteristic of this age group. The levels of WBC, LY, MO and MID should be investigated 
to exclude leukocytosis, leukopenia and various infections. Cancer, allergies and anemia 
should be considered. Genetic testing may be necessary. In the interpretation of the result, 
attention should be paid to the level of deviation from the norm and to extend the diagnosis in 
case of any doubts. Arterial blood gas measurement is performed primarily in patients with 
COPD and intensive care units. It is used in simple diagnostics of acidosis and hypercapnia, 
which results in a poor prognosis of the patient. Venous blood is also suitable for blood gas 
testing. In order to broaden the diagnosis and make the right diagnosis, it is worth checking 
the cancer markers, especially those diseases that most often occur in geriatric patients. These 
include markers characterizing breast cancer, lung and bronchus, prostate, colon and rectum 
as well as pancreas. There are also markers that are detected not only in cancer but also in 
other benign conditions. It should be remembered that there are markers (CA-125) that also 
grow in the course of other neoplastic diseases than those characteristic of themselves. 
Markers play the role of monitoring the course of the disease. Blood tests in a geriatric 
patient are necessary in emergencies and life-threatening situations. Performing these tests 
and their quick interpretation allow you to take appropriate actions to save health and life. In 
addition, proper diagnosis reduces the cost of hospital treatment. The most common 
parameters that are tested for emergency diagnosis are glucose, morphology, troponin I, urea, 
enzymes, electrolytes, creatinine. Also, be sure to examine the brain natriuretic peptide 
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(BNP), von Willebrand factor (vWF), TNF-alpha, neurospecific enolase (NSE), leptin and 
high-sensitivity cardiac troponins (hs-cTn) in the blood. Laboratory diagnostics of blood is 
becoming more and more modern. Its purpose is not only to diagnose numerous diseases, but 
also to predict further treatment. 
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